Software (Bioinformatics) Engineer 1 at Illumina

Cambridge, England, United Kingdom

Illumina Logo
Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Biotechnology, GenomicsIndustries

Requirements

  • Strong Python skills
  • Passionate software engineer with a strong foundation in programming
  • Keen interest in bioinformatics
  • Experience in Linux environments
  • Comfortable working with cloud technologies
  • Experience in Python, Java, C#, or C++
  • Exposure to CI/CD tools and automated testing frameworks
  • Familiarity with database design, web development, or data visualization tools (a plus)
  • Bachelor's degree in Computer Science or a related field (implied)

Responsibilities

  • Design and develop automated software verification frameworks for genomic analysis tools
  • Ensure robustness and scalability across verification workflows
  • Partner with bioinformatics scientists to design, troubleshoot, and optimize tools for large-scale genomic datasets
  • Translate scientific requirements into reliable software solutions
  • Improve CI/CD pipelines and internal databases
  • Enhance web platforms used for verification and reporting
  • Participate in code and design reviews to uphold high software standards
  • Drive continuous improvement across the software development lifecycle

Skills

Python
Java
C#
C++
Linux
Cloud Technologies
CI/CD
Automated Testing
Bioinformatics
Software Engineering

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI